LIPEGFILGRASTIM: 425 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
425
Total FAERS Reports
41 (9.6%)
Deaths Reported
248
Hospitalizations
425
As Primary/Secondary Suspect
49
Life-Threatening
4
Disabilities
First Report: 20140422 · Latest Report: 20250818
What Are the Most Common LIPEGFILGRASTIM Side Effects?
#1 Most Reported
Neutropenia
60 reports (14.1%)
#2 Most Reported
Thrombocytopenia
55 reports (12.9%)
#3 Most Reported
General physical health deterioration
44 reports (10.4%)
All LIPEGFILGRASTIM Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 60 | 14.1% | 2 | 21 |
| Thrombocytopenia | 55 | 12.9% | 1 | 21 |
| Febrile neutropenia | 44 | 10.4% | 2 | 18 |
| General physical health deterioration | 44 | 10.4% | 1 | 43 |
| Pyrexia | 37 | 8.7% | 3 | 32 |
| Diarrhoea | 34 | 8.0% | 1 | 27 |
| Anaemia | 30 | 7.1% | 0 | 24 |
| Dyspnoea | 26 | 6.1% | 0 | 24 |
| Leukopenia | 26 | 6.1% | 1 | 1 |
| Headache | 25 | 5.9% | 0 | 24 |
| Fatigue | 23 | 5.4% | 0 | 16 |
| Pain | 23 | 5.4% | 2 | 17 |
| Abdominal pain | 22 | 5.2% | 0 | 17 |
| Pneumonia | 22 | 5.2% | 1 | 11 |
| Dizziness | 20 | 4.7% | 1 | 18 |
| Leukocytosis | 20 | 4.7% | 0 | 11 |
| Lymphopenia | 20 | 4.7% | 0 | 0 |
| Bone pain | 19 | 4.5% | 0 | 13 |
| Malaise | 19 | 4.5% | 0 | 14 |
| Paraesthesia | 19 | 4.5% | 0 | 17 |
Who Reports LIPEGFILGRASTIM Side Effects? Age & Gender Data
Gender: 50.0% female, 50.0% male. Average age: 56.4 years. Most reports from: DE. View detailed demographics →
Is LIPEGFILGRASTIM Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2014 | 13 | 0 | 3 |
| 2015 | 48 | 7 | 37 |
| 2016 | 85 | 11 | 54 |
| 2017 | 79 | 1 | 32 |
| 2018 | 32 | 3 | 16 |
| 2019 | 18 | 2 | 12 |
| 2020 | 16 | 1 | 4 |
| 2021 | 10 | 8 | 10 |
| 2023 | 3 | 0 | 2 |
| 2025 | 1 | 0 | 1 |
What Is LIPEGFILGRASTIM Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 124 |
| Prophylaxis | 94 |
| Neutropenia | 66 |
| Breast cancer | 30 |
| Colony stimulating factor prophylaxis | 16 |
| B-cell lymphoma | 12 |
| Colony stimulating factor therapy | 5 |
| Exposure during pregnancy | 5 |
LIPEGFILGRASTIM vs Alternatives: Which Is Safer?
LIPEGFILGRASTIM vs LIPITOR
LIPEGFILGRASTIM vs LIRAGLUTIDE
LIPEGFILGRASTIM vs LISDEXAMFETAMINE
LIPEGFILGRASTIM vs LISDEXAMFETAMINE DIMESYLATE
LIPEGFILGRASTIM vs LISINOPRIL
LIPEGFILGRASTIM vs LISOCABTAGENE MARALEUCEL
LIPEGFILGRASTIM vs LITHIUM
LIPEGFILGRASTIM vs LIXISENATIDE
LIPEGFILGRASTIM vs LOBAPLATIN
LIPEGFILGRASTIM vs LOFEXIDINE
Official FDA Label for LIPEGFILGRASTIM
Official prescribing information from the FDA-approved drug label.